ABCG2 Overexpression Contributes to Pevonedistat Resistance.
MLN4924 (pevonedistat) is a first-in-class NEDD8-activating enzyme (NAE) inhibitor in clinical...
Read More
OBGYN Old
Vitamin D Exposure and Ovarian Cancer Risk and Prognosis.
Given the poor prognosis of ovarian cancer and limited population-level strategies for early...
Read More
TGF-β1 fucosylation enhances the autophagy and mitophagy via PI3K/Akt and Ras-Raf-MEK-ERK in ovarian carcinoma.
Transforming growth factor-β, a cell secretion factor of the TGF-β superfamily, is involved in the...
Read More
The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer.
Clear cell ovarian carcinoma (CCOC) is an aggressive disease that often demonstrates resistance to...
Read More
IL-1 Signaling in Tumor Microenvironment.
Interleukin 1 (IL-1) has long been known for its pleiotropic effects on inflammation that plays a...
Read More
Low-Dose, Contrast-Enhanced Mammography Compared to Contrast-Enhanced Breast MRI: A Feasibility Study.
Contrast-enhanced MRI (CE-MRI) is the most sensitive technique for breast cancer detection....
Read More
Cyclins E1 and E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targets.
Cyclin E1 is one the most promising biomarkers in estrogen receptor positive (ER+) breast cancer...
Read More
Molecular heterogeneity in breast carcinoma cells with increased invasive capacities.
Background Metastatic progression of breast cancer is still a challenge in clinical oncology....
Read More
Transgelin Silencing Induces Different Processes in Different Breast Cancer Cell Lines.
Transgelin is a protein reported to be a marker of several cancers. However, previous studies have...
Read More